# Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients

> **NCT07407400** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mahidol University** · enrollment: 100 (estimated)

## Conditions studied

- Sleep Disturbance
- Delirium
- Critical Illness

## Interventions

- **DRUG:** Lemborexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07407400
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07407400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07407400, "Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT07407400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*